New cancer clinical trial: A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Published on: February 05, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share